State Of Wisconsin Investment Board Viking Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$36.2 Billion
Q2 2024

A detailed history of State Of Wisconsin Investment Board transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 82,773 shares of VKTX stock, worth $5.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

82,773

Previous 68,610 20.64%

Holding current value

$5.67 Million

Previous $5.63 Million 22.02%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $671,184 - $1.14 Million	14,163 Added 20.64%	82,773 $4.39 Million
Q1 2024 May 14, 2024	SELL	$17.4 - $94.5 $151,849 - $824,701	-8,727 Reduced 11.28%	68,610 $5.63 Million
Q4 2023 Feb 12, 2024	SELL	$9.24 - $19.64 $122,291 - $259,935	-13,235 Reduced 14.61%	77,337 $1.44 Million
Q3 2023 Nov 14, 2023	SELL	$10.92 - $16.0 $1,146 - $1,680	-105 Reduced 0.12%	90,572 $1 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $400,383 - $668,834	26,980 Added 42.36%	90,677 $1.47 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $514,671 - $1.1 Million	63,697 New	63,697 $1.06 Million
Q4 2021 Feb 11, 2022	SELL	$4.6 - $6.72 $409,399 - $598,080	-89,000 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$5.3 - $6.71 $58,830 - $74,481	-11,100 Reduced 11.09%	89,000 $501,000
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $1.6 Million - $2.26 Million	-278,780 Reduced 73.58%	100,100 $583,000
Q2 2020 Aug 12, 2020	BUY	$4.35 - $8.08 $53,504 - $99,384	12,300 Added 3.36%	378,880 $2.73 Million
Q1 2020 May 06, 2020	BUY	$3.45 - $7.95 $182,915 - $421,501	53,019 Added 16.91%	366,580 $1.72 Million
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $1.38 Million - $1.89 Million	216,261 Added 222.26%	313,561 $2.52 Million
Q3 2019 Nov 12, 2019	BUY	$6.55 - $8.6 $87,770 - $115,240	13,400 Added 15.97%	97,300 $669,000
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $13,806 - $19,134	1,800 Added 2.19%	83,900 $696,000
Q1 2019 May 13, 2019	BUY	$7.58 - $9.94 $216,788 - $284,284	28,600 Added 53.46%	82,100 $816,000
Q4 2018 Feb 11, 2019	BUY	$7.16 - $16.21 $47,256 - $106,986	6,600 Added 14.07%	53,500 $409,000
Q2 2018 Aug 03, 2018	BUY	$3.88 - $12.74 $181,972 - $597,506	46,900 New	46,900 $445,000

Others Institutions Holding VKTX

# of Institutions

480

Shares Held

66.2M

Call Options Held

6.24M

Put Options Held

3.01M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $5.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Viking Therapeutics, Inc. Transaction History